Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6133440

Process for the preparation of immunomodulatory polysaccharides from aloe

Univera Pharmaceuticals, Inc. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133424

ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product

The Regents of the University of California · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133343

Resinous composition for dental use

KURARAY CO., LTD. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133324

Use of perillyl alcohol in organ transplantation

The Regents of the University of California · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133320

Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or

The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133295

Pharmaceutical composition

Takeda Chemical Industries Ltd. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133293

Pharmaceutical composition

Takeda Chemical Industries Ltd. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133278

Use of quinone and hydroquinone derivatives for the treatment of cachexia

Takeda Chemical Industries Ltd. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133276

Compounds and methods for increasing endogenous levels of corticotropin-releasing factor

Neurocrine Biosciences, Inc. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133256

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133240

Tetrahydronapthalene derivatives and their therapeutic use

Darwin Discovery Limited · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133232

Endoderm, cardiac and neural inducing factors

The Regents of the University of California · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6132987

Recombinant mammalian monocyte chemotactic protein-1 (MCP-1) receptors (MCP-1R, CCR-2)

The Regents of the University of California · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6132980

Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6132962

Retroviral vectors comprising an anti-hiv or other nucleic acid

The Regents of the University of California · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6132732

Parvovirus capsids

expired patent

US 6132730

Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor

expired patent

US 6132729

Combined tissue factor and chemotherapeutic methods and compositions for coagulation and t

expired patent

US 6129914

Bispecific antibody effective to treat B-cell lymphoma and cell line

Protein Design Labs, Inc. · Granted Tue Oct 10 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6130254

Methods for inhibiting photoaging of skin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 10 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6126944

Baculovirus expression vectors and recombinant antigens for detecting type-specific antibo

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6128582

Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6127598

NKX-2.2 and NKX-6.1 transgenic mouse models for diabetes, depression, and obesity

The Regents of the University of California · Granted Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6127426

10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired